An overview of topical antibiotics for acne treatment

Dermatology

Volumn 196, Issue 1, 1998, Pages 130-134

  Toyoda, M ^a,b   Morohashi, M ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b University of Toyama   (Japan)

Author keywords

Acne; Clindamycin; Erythromycin; Nadifloxacine; Propionibacterium acnes; Tetracycline; Topical antibiotics

Indexed keywords

ANTIBIOTIC AGENT; BENZOYL PEROXIDE; CLINDAMYCIN; ERYTHROMYCIN; RETINOIC ACID; TETRACYCLINE; ZINC;

ACNE; BACTERICIDAL ACTIVITY; CONFERENCE PAPER; CONTACT DERMATITIS; DRUG EFFICACY; ERYTHEMA; HUMAN; INFLAMMATION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PRURITUS; PSEUDOMEMBRANOUS COLITIS; SEBUM SECRETION; SIDE EFFECT; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; HUMANS; PROPIONIBACTERIUM ACNES;

EID: 0031904933     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017846     Document Type: Conference Paper

References (31)

1. Berson DS, Shalita AR: The treatment of acne: The role of combination therapy. J Am Acad Dermatol 1995;332:S31-S41.
2. Pochi PE: The pathogenesis and treatment of acne. Annu Rev Med 1990;41:187-198.
3. Thiboutot DM: An overview of acne and its treatment. Cutis 1996;57:8-12.
4. Lyden JJ, McGinley KJ, Mills OH, Kligman AM: Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975;65:382-384.
5. Eady EA, Holland KT, Cunliffe WJ: Should topical antibiotics be used for the treatment of acne vulgaris? Br J Dermatol 1982;107: 235-240.
6. Webster GF, McGinley KJ, Leyden JJ: Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin. Br J Dermatol 1981;104:453-457.
7. Elewski BE, Sam M Jr, Gammon WR: In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol 1983;8:807-812.
8. Thong UH, Ferrante A: Inhibition of mitogen-induced human lymphocyte proliferation responses by tetracycline analogs. Clin Exp Immunol 1979;35:443-446.
9. Eady EA, Joanes DN, Cunliffe WJ: Topical antibiotics for the treatment of acne vulgaris: A critical evaluation of the literature on their clinical benefit and comparative efficacy. J Dermatol Treat 1990;1:215-226.
10. Habbema L, Koopmans B, Menke HE, Doornweerd S, Boulle KD: A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: A randomized, double-blind comparative study. Br J Dermatol 1989;121:497-502.
11. Cook CH, Centner RL, Michaels SE: An acnegrading method using photographic standards. Arch Dermatol 1979;115:571-575.
12. Strauss JS, Stranieri AM: Acne treatment with topical erythromycin and zinc: Effect on Propionibacterium acnes and free fatty acid composition. J Am Acad Dermatol 1984;11:86-89.
13. Burke B, Eady EA, Cunliffe WJ: Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris. Br J Dermatol 1983; 108:199-204.
14. Chalker DK, Shalita A, Smith JG, Swann RW: A double blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983;9:933-936.
15. Ellis CN, Gammon WR, Stone DZ, Heezen-Wehner JL: A comparison of Cleocin-T solution, Cleocin-T gel and placebo in the treatment of acne vulgaris. Cutis 1988;42:245-247.
16. Shalita AR, Smith EB, Bauer E: Topical erythromycin vs clindamycin therapy for acne: A multicenter, double-blind comparison. Arch Dermatol 1984;120:351-355.
17. Swinyer LJ, Baker MD, Swinyer TA, Swinyer TA, Mills OH Jr: A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris. Br J Dermatol 1988; 119:615-622.
18. Wechsler HL, Kirk J, Slone J: Acne treated with a topical tetracycline preparation: Results of a one-year multi-group study. Int J Dermatol 1978;17:237-242.
19. Tucker SB, Tausend R, Cochran R, Flannigan SA: Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris. Br J Dermatol 1984;110:487-492.
20. Leyden J, Shalita A: Rational therapy for acne vulgaris: An update on topical treatment. J Am Acad Dermatol 1986;15:907-915.
21. Mills OH, Kligman AM: Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm Venereol (Stockh) 1978;58:555-557.
22. Rietschel R, Duncan BS: Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Int J Dermatol 1983;22: 41-43.
23. Mills OH, Berger RS: A double-blind evaluation of tretinoin alone and in combination with erythromycin/benzoyl peroxide in acne vulgaris. Cutis 1992;49:12-15.
24. Knutson DD, Swinyer LJ, Smoot WH: Meclocycline sulfosalicylate: Topical antibiotic agent for the treatment of acne vulgaris. Cutis 1981;27:203-210.
25. Kurokawa I, Akamatsu H, Nishijima S, Asada Y, Kawabata S, Kuwabata S: Clinical and bacteriologic evaluation of OPC-7251 in patients with acne: A double-blind group comparison study versus cream base. J Am Acad Dermatol 1991;25:674-681.
26. Vogt K, Hahn H, Hermann J, Haustein UF, Blume U, Gollnick H, Orfanos CE: Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris. Drugs 1995;49(suppl 2):266-268.
27. Milstone EB, McDonald AJ, Scholhamer CF: Pseudomembraneous colitis after topical application of clindamycin. Arch Dermatol 1981; 117:154-155.
28. Parry MF, Rha CK: Pseudomembraneous colitis caused by topical clindamycin phosphate. Arch Dermatol 1986;122:583-584.
29. Rothman KF, Pochi PE: Use of oral and topical agents for acne in pregnancy. J Am Acad Dermatol 1988;19:431-432.
30. Eady EA, Cove JH, Holland KT, Cunliffe WJ: Erytromycin-resistant propionibacteria in antibiotic-treated acne patients: Association with therapeutic failure. Br J Dermatol 1989;121: 51-57.
31. Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ: Effects of erythromycin and benzoyl peroxide alone and in combination against antibiotic-sensitive and resistant skin bacteria from acne patients. Br J Dermatol 1994;131: 331-336.